New Jersey Vioxx Trial Set to Close
In final pitches to the jury, lawyers for Merck & Co. and two men suing over its troubled arthritis drug Vioxx were to present summations Monday as the four-week trial neared a close.
April 3, 2006
Merck loses Vioxx case, told to pay $51 million
A federal jury on Thursday found that Merck & Co. Inc. was negligent and knowingly made misrepresentations about its withdrawn pain medicine Vioxx, and awarded $51 million to the plaintiff.
Researchers say Vioxx study was marketing ploy
TRENTON, N.J. — A 1999 Merck & Co. study of its since-withdrawn painkiller Vioxx, touted to participating doctors and patients as meant to show whether Vioxx caused fewer stomach problems than another drug, was primarily a stealth marketing strategy, researchers report.
Vioxx Gains Big Win with N.J. High Court's Rejection of Class Action
New Jersey's Supreme Court has rejected a class-action lawsuit against Merck & Co. over its withdrawn painkiller Vioxx. The ruling is a huge legal victory for the drugmaker, which faces nearly 27,0
